Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-006020
Filing Date
2025-01-24
Accepted
2025-01-24 16:44:06
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm254414-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm254414-1_4seq1.xml 4 9016
  Complete submission text file 0001104659-25-006020.txt   10569
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Issuer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1350 TREAT BLVD SUITE 250 WALNUT CREEK CA 94596
Business Address
ROSS GEORGE K (Reporting) CIK: 0001068724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10113 | Film No.: 25554716